MX365851B - Compuestos de benzofurazano anti-amiloides y metodos. - Google Patents

Compuestos de benzofurazano anti-amiloides y metodos.

Info

Publication number
MX365851B
MX365851B MX2015002418A MX2015002418A MX365851B MX 365851 B MX365851 B MX 365851B MX 2015002418 A MX2015002418 A MX 2015002418A MX 2015002418 A MX2015002418 A MX 2015002418A MX 365851 B MX365851 B MX 365851B
Authority
MX
Mexico
Prior art keywords
methods
benzofurazan
compounds
phenyl
amyloid compounds
Prior art date
Application number
MX2015002418A
Other languages
English (en)
Other versions
MX2015002418A (es
Inventor
A Reed Mark
K Wood Thomas
C Banfield Scott
J Barden Christopher
Original Assignee
Treventis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treventis Corp filed Critical Treventis Corp
Publication of MX2015002418A publication Critical patent/MX2015002418A/es
Publication of MX365851B publication Critical patent/MX365851B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/001—Cooling arrangements
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/003—Insulating arrangements
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/04—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones using electrical heaters
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L11/00—Hoses, i.e. flexible pipes
    • F16L11/20—Double-walled hoses, i.e. two concentric hoses
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L53/00—Heating of pipes or pipe systems; Cooling of pipes or pipe systems
    • F16L53/30—Heating of pipes or pipe systems
    • F16L53/35—Ohmic-resistance heating
    • F16L53/38—Ohmic-resistance heating using elongate electric heating elements, e.g. wires or ribbons
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L9/00—Rigid pipes
    • F16L9/18—Double-walled pipes; Multi-channel pipes or pipe assemblies
    • F16L9/19—Multi-channel pipes or pipe assemblies
    • F16L9/20—Pipe assemblies
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02G—INSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
    • H02G3/00—Installations of electric cables or lines or protective tubing therefor in or on buildings, equivalent structures or vehicles
    • H02G3/36—Installations of cables or lines in walls, floors or ceilings
    • H02G3/38—Installations of cables or lines in walls, floors or ceilings the cables or lines being installed in preestablished conduits or ducts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mining & Mineral Resources (AREA)
  • Geology (AREA)
  • General Engineering & Computer Science (AREA)
  • Fluid Mechanics (AREA)
  • Environmental & Geological Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Structural Engineering (AREA)
  • Civil Engineering (AREA)
  • Architecture (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Laying Of Electric Cables Or Lines Outside (AREA)

Abstract

En general, entre otras cosas, en la presente invención se proporcionan los compuestos de Fórmula I: en donde R11 se relaciona del grupo que consiste de bencilalmino, N-metilbencilamino, morfolino, tiomorfolino, pirrolidino, entre otros sustituyentes; R13 se selecciona del grupo que consiste de 3- (1-etanol-2-il) fenilo, 3-(1-ol-2,2,2-trifluoroetan-2-il) fenilo, 2-(1-o1-2,2,2-trifluoroetan-2-il) fenilo, entre otros sustituyentes; y R12 y R14 son cada uno independientemente hidrógeno o alquilo. También se proporcionan usos farmacéuticos y métodos de tratamiento terapéuticos.
MX2015002418A 2012-08-24 2013-08-22 Compuestos de benzofurazano anti-amiloides y metodos. MX365851B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261693011P 2012-08-24 2012-08-24
PCT/US2013/056220 WO2014031873A2 (en) 2012-08-24 2013-08-22 Benzofurazan anti-amyloid compounds and methods

Publications (2)

Publication Number Publication Date
MX2015002418A MX2015002418A (es) 2015-09-21
MX365851B true MX365851B (es) 2019-06-17

Family

ID=50150397

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002418A MX365851B (es) 2012-08-24 2013-08-22 Compuestos de benzofurazano anti-amiloides y metodos.

Country Status (14)

Country Link
US (2) US9328078B2 (es)
EP (1) EP2888252B1 (es)
JP (1) JP6219955B2 (es)
KR (1) KR102046499B1 (es)
CN (1) CN104768949A (es)
AU (1) AU2013305663B2 (es)
BR (1) BR112015003824B1 (es)
CA (1) CA2883221C (es)
IL (1) IL237305B (es)
MX (1) MX365851B (es)
NZ (1) NZ705167A (es)
RU (1) RU2641293C2 (es)
WO (2) WO2014031873A2 (es)
ZA (1) ZA201501161B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9938249B2 (en) * 2014-02-27 2018-04-10 Treventis Corporation Anti-amyloid compounds containing benzofurazan
DE102014214687A1 (de) * 2014-07-25 2016-01-28 Contitech Techno-Chemie Gmbh Beheizbarer Schlauch
EP3634950B1 (en) 2017-06-06 2022-03-09 Council of Scientific and Industrial Research Cobalt complexes, process for preparation and use thereof
CN108235475B (zh) * 2017-11-27 2021-01-22 安邦电气股份有限公司 一种便于使用的伴热带
CN108566693B (zh) * 2017-11-27 2020-12-25 安邦电气股份有限公司 一种高效率伴热带
WO2022015859A1 (en) * 2020-07-14 2022-01-20 Washington University Compositions for cancer therapy and imaging

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971416A (en) * 1974-08-16 1976-07-27 Thermon Manufacturing Company Preinsulated pipe assembly and pipeline
DE19643037A1 (de) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
JP2002228081A (ja) * 2001-02-06 2002-08-14 Nitta Moore Co 保温・移送用配管
JP2005511625A (ja) * 2001-11-14 2005-04-28 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 向精神薬としてのピラゾール誘導体
JP2003328402A (ja) * 2002-05-16 2003-11-19 Sekisui Chem Co Ltd ヒータ挿入ガイド付き管
GB0228410D0 (en) * 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds
JP2004244958A (ja) * 2003-02-14 2004-09-02 Sekisui Chem Co Ltd 凍結防止用流水配管
GB0328900D0 (en) * 2003-12-12 2004-01-14 Glaxo Group Ltd Novel compounds
EP1758873A1 (en) * 2004-06-22 2007-03-07 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
GB2423811A (en) * 2005-03-02 2006-09-06 Valpar Ind Ltd Improved Beverage Python
NZ591896A (en) * 2008-08-29 2013-03-28 Treventis Corp Compositions and methods of treating amyloid disease
ES2553610T3 (es) * 2010-12-14 2015-12-10 Electrophoretics Limited Inhibidores de la caseína cinasa 1 delta (CK1delta)

Also Published As

Publication number Publication date
US20160264535A1 (en) 2016-09-15
JP6219955B2 (ja) 2017-10-25
EP2888252B1 (en) 2017-06-07
WO2014031942A1 (en) 2014-02-27
BR112015003824A2 (pt) 2018-05-29
KR20150046263A (ko) 2015-04-29
US9328078B2 (en) 2016-05-03
EP2888252A4 (en) 2016-01-06
WO2014031873A3 (en) 2014-04-17
BR112015003824B1 (pt) 2022-10-04
CA2883221A1 (en) 2014-02-27
CA2883221C (en) 2020-01-21
ZA201501161B (en) 2016-06-29
AU2013305663B2 (en) 2017-11-02
RU2641293C2 (ru) 2018-01-17
US20150266838A1 (en) 2015-09-24
WO2014031873A2 (en) 2014-02-27
RU2015110256A (ru) 2016-10-10
JP2015526475A (ja) 2015-09-10
EP2888252A2 (en) 2015-07-01
AU2013305663A1 (en) 2015-03-05
IL237305B (en) 2018-08-30
IL237305A0 (en) 2015-04-30
KR102046499B1 (ko) 2019-11-19
MX2015002418A (es) 2015-09-21
CN104768949A (zh) 2015-07-08
NZ705167A (en) 2017-12-22

Similar Documents

Publication Publication Date Title
MX365851B (es) Compuestos de benzofurazano anti-amiloides y metodos.
NZ705705A (en) Ret inhibitor
CY1118129T1 (el) 5-αλκυνυλ-πυριμιδινες
PH12014502169A1 (en) N-cyclylamides as nematicides
MX2014002624A (es) Nuevos derivados biciclicos de dihidroquinolina-2-ona.
MY176680A (en) Cyclic amides as metap-2 inhibitors
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
MX2016006432A (es) Tetrahidro-benzodiazepinonas.
MX358376B (es) Nuevos derivados dihidroquinolina-2-ona.
NZ703950A (en) Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
MX359032B (es) Inhibidores de pirrolopirazina cinasa.
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX368346B (es) Derivados de 1,6- diazabiciclo [3.2,1] octano-7-ona y su uso en el tratamiento de las infecciones bacterianas.
MX2015007097A (es) Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
JO3131B1 (ar) مركبات كيميائية
MX2014002208A (es) Inhibidores de serina/treonina quinasa.
MX343225B (es) Nuevos derivados de aril-benzocicloalquil-amida.
MX2015001099A (es) Nuevos derivados biciclicos de piridina.
MX2012008141A (es) Compuestos y metodos.
MD20170011A2 (ro) Compuşi imidazopiridazinici
MY178390A (en) Inhibitors of iap
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
MX2013005819A (es) Benzoxazepinas como inhibidores de 3-cinasa/objetivo mamífero de rapamicina (pi3k/mtor) metodos de uso y fabricacion.
MX345624B (es) Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor.
SI2608789T1 (sl) Terapevtske uporabe 1-(2-(2,4-dimetil-fenilsulfanil) fenil) piperazina

Legal Events

Date Code Title Description
FG Grant or registration